Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool
Journal of Controlled Release · 2024-11 · 375 · 389-403
DOI: 10.1016/j.jconrel.2024.09.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-11. Verfasst von Yanou Engelen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium; Cancer Research …. Hauptthemen laut MEDLINE: Immunogenic Cell Death, High-Intensity Focused Ultrasound Ablation, HMGB1 Protein. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, PATH, Belgian Federal Government.
Abstract (Originalsprache)
Over the past decade, ultrasound (US) has gathered significant attention and research focus in the realm of medical treatments, particularly within the domain of anti-cancer therapies. This growing interest can be attributed to its non-invasive nature, precision in delivery, availability, and safety. While the conventional objective of US-based treatments to treat breast, prostate, and liver cancer is the ablation of target tissues, the introduction of the concept of immunogenic cell death (ICD) has made clear that inducing cell death can take different non-binary pathways through the activation of the patient's anti-tumor immunity. Here, we investigate high-intensity focused ultrasound (HIFU) to induce ICD by unraveling the underlying physical phenomena and resulting biological effects associated with HIFU therapy using an automated and fully controlled experimental setup. Our in-vitro approach enables the treatment of adherent cancer cells (B16F10 and CT26), analysis for ICD hallmarks and allows to monitor and characterize in real time the US-induced cavitation activity through passive cavitation detection (PCD). We demonstrate HIFU-induced cell death, CRT exposure, HMGB1 secretion and antigen release. This approach holds great promise in advancing our understanding of the therapeutic potential of HIFU for anti-cancer strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium; Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium; Ghent Research Group on N…
- Cancer Research Institute Ghent (CRIG), 9000 Ghent, Belgium; Cell Death Investigation and Therapy (CDIT) Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health…
- Laboratory for Molecular and Cellular Therapy, Translational Oncology Research Center, Department of Biomedical Sciences, Faculty of Pharmacy and Medicine, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
- Physics of Fluids Group, Technical Medical (TechMed) Center, and Max Planck Center for Complex Fluid Dynamics, University of Twente, Enschede, the Netherlands.
Förderung
- Fonds Wetenschappelijk Onderzoek
- PATH
- Belgian Federal Government
Zitieren
APA
Engelen, Y., Krysko, D. V., Effimova, I., Breckpot, K., Versluis, M., De Smedt, S., Lajoinie, G., & Lentacker, I. (2024). Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool. Journal of Controlled Release, 375, 389-403. https://doi.org/10.1016/j.jconrel.2024.09.016
Vancouver
Engelen Y, Krysko DV, Effimova I, Breckpot K, Versluis M, De Smedt S, et al. Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool. Journal of Controlled Release. 2024;375:389-403. doi:10.1016/j.jconrel.2024.09.016
BibTeX
@article{Engelen2024,
author = {Engelen, Yanou and Krysko, Dmitri V and Effimova, Iuliia and Breckpot, Karine and Versluis, Michel and De Smedt, Stefaan and Lajoinie, Guillaume and Lentacker, Ine},
title = {Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool},
journal = {Journal of Controlled Release},
year = {2024},
volume = {375},
pages = {389--403},
doi = {10.1016/j.jconrel.2024.09.016}
}
EUVIMED